All Pharma News
BioMarin axes 4 candidates, centers R&D around 3 assets

BioMarin axes 4 candidates, centers R&D around 3 assets
Gabrielle Masson FIERCE BIOTECH
26 Apr 2024
Share Share
BioMarin`s Roctavian struggles continue. Is a divestment in the future?

BioMarin`s Roctavian struggles continue. Is a divestment in the future?
Nicole DeFeudis ENDPTS
24 Apr 2024
Share Share
BioMarin Reports Record Financial Results for the First Quarter 2024

BioMarin Reports Record Financial Results for the First Quarter 2024
PR NEWSWIRE
24 Apr 2024
Share Share
Ex-BioMarin CEO Bienaimé re-emerges at Owkin

Ex-BioMarin CEO Bienaimé re-emerges at Owkin
PHARMAPHORUM
26 Mar 2024
Share Share
New Data to be Presented for BioMarin`s VOXZOGO

New Data to be Presented for BioMarin`s VOXZOGO
PR NEWSWIRE
12 Mar 2024
Share Share
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer

BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
PR NEWSWIRE
07 Mar 2024
Share Share
BioMarin Scheduled to Participate in March Investor Conferences

BioMarin Scheduled to Participate in March Investor Conferences
PR NEWSWIRE
01 Mar 2024
Share Share
BioMarin gets DOJ subpoena on sponsored testing programs for two therapies

BioMarin gets DOJ subpoena on sponsored testing programs for two therapies
REUTERS
26 Feb 2024
Share Share
BioMarin`s Roctavian, once forecast to sell $50M to $150M last year, only pulls in a fraction of that

BioMarin`s Roctavian, once forecast to sell $50M to $150M last year, only pulls in a fraction of that
ENDPTS
23 Feb 2024
Share Share
BioMarin Reports Record Financial Results for Fourth Quarter and Full-year 2023

BioMarin Reports Record Financial Results for Fourth Quarter and Full-year 2023
PRESS RELEASE
22 Feb 2024
Share Share